TNMG TNL Mediagene IFRS Annual reports only
Services-Advertising · Nasdaq · SEC CIK 2013186 · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY35.3%
TTM net income YoY-10,459.9%
TTM EPS YoY-8,550.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin36.6%
Operating margin-157.4%
Net margin-175.3%
FCF margin-21.2%
EBITDA margin-150.7%
Returns
ROE-155.9%
ROA-80.0%
ROIC (approx.)-102.0%
Asset turnover0.46x
Leverage & solvency
Liabilities / assets60.8%
Debt / equity0.27x
Current ratio0.54x
Interest coverage-9.35x
Cash quality & payout
Operating cash flow / net income0.12x
Accruals ratio-70.4%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | $48.49M | $35.84M | $20.01M |
| Cost of revenue | $30.76M | $23.19M | $12.27M |
| Gross profit | $17.74M | $12.65M | $7.74M |
| R&D expense | $3.05M | $3.33M | $2.51M |
| SG&A expense | $62.00M | $16.42M | $8.65M |
| Operating income | -$76.34M | -$7.40M | -$3.42M |
| Interest expense | $8.17M | $298,958 | $137,029 |
| Pretax income | -$85.28M | -$1.81M | -$11.64M |
| Income tax | -$307,246 | -$591,082 | -$247,177 |
| Net income | -$85.00M | -$804,977 | -$11.01M |
| EBITDA | -$73.10M | -$4.56M | — |
| EPS (basic) | -3.46 | -0.04 | -1.20 |
| EPS (diluted) | -3.46 | -0.04 | -1.20 |
| Balance sheet | |||
| Cash & equivalents | $3.65M | $3.03M | $3.73M |
| Receivables | $8.24M | $8.85M | — |
| Inventory | $87,828 | $115,624 | — |
| Current assets | $17.72M | $16.85M | — |
| PP&E, netmay include right-of-use assets (IFRS) | $430,809 | $537,014 | $77,467 |
| Goodwill | $33.96M | $60.74M | — |
| Intangibles | $30.98M | $33.41M | — |
| Total assets | $92.92M | $119.62M | — |
| Current liabilities | $32.99M | $24.90M | — |
| Short-term debt | $4.84M | $3.12M | — |
| Long-term debt | $4.84M | $3.12M | — |
| Total debt | $9.69M | $6.24M | — |
| Total liabilities | $56.51M | $47.25M | — |
| Shareholders' equity | $36.40M | $72.62M | -$24.14M |
| Net debt | $6.04M | $3.21M | — |
| Shares outstanding | 26.13M | 24.20M | 9.21M |
| Cash flow statement | |||
| Operating cash flow | -$10.21M | -$1.42M | -$760,106 |
| Capital expenditure | $89,121 | $87,179 | $52,481 |
| Free cash flow | -$10.30M | -$1.51M | -$812,587 |
| Investing cash flow | $922,857 | $252,741 | -$2.36M |
| Financing cash flow | $10.02M | $530,972 | $4.99M |
| Depreciation & amortization | $3.24M | $2.84M | — |
| Stock-based compensation | $250,952 | $118,800 | $237,301 |
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.